Synthesis, pharmacological evaluation, drug-likeness prediction, and molecular docking studies of some new N-[4-(5-phenyl-[1,3,4]oxadiazol-2-yl)-naphthalen-1-yl]-acetamide derivatives as potential anticonvulsants